L. Han

机构：Xuzhou Central Hospital

发表论文 4 篇 · 总被引 3 次 · h-index 1

代表论文

• 1166P A phase I study of JS207, a PD-1/VEGF bispecific antibody, in patients with advanced malignancies (2025 · Annals of Oncology · 被引 2)
• LBA11 A phase II clinical study of dose optimization for ZG006 (Alveltamig) in patients with advanced small cell lung cancer who have received at least two prior lines of therapy (ZG006-002) (2025 · Annals of Oncology · 被引 1)
• 1069eP Crossover-adjusted overall survival (OS) benefit with sintilimab in EGFR-TKI-resistant NSCLC: Post-hoc analysis of ORIENT-31 (2025 · Annals of Oncology)
• 928MO ARTEMIS-001: A phase I study of HS-20093 (GSK5764227) in patients with non-small cell lung cancer (NSCLC) (2025 · Annals of Oncology)